{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:10:49Z","timestamp":1760015449591},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijid.2016.12.014","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T13:00:42Z","timestamp":1481720442000},"page":"24-26","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient"],"prefix":"10.1016","volume":"55","author":[{"given":"Diego O.","family":"Andrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Emonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Erard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.12.014_bib0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1586\/eri.11.66","article-title":"Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment","volume":"9","author":"Caira","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijid.2016.12.014_bib0090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.12.014_bib0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1439-0507.2005.01167.x","article-title":"Cerebral zygomycosis","volume":"48","author":"Sundaram","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2016.12.014_bib0100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/14787210.3.5.775","article-title":"Fungal CNS infections in patients with hematologic malignancy","volume":"3","author":"Pagano","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijid.2016.12.014_bib0105","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/jac\/dks268","article-title":"A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers","volume":"67","author":"Krishna","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0110","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1128\/AAC.00222-12","article-title":"Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension","volume":"56","author":"Krishna","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/IDR.S65592","article-title":"Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole","volume":"8","author":"Soysal","year":"2015","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2016.12.014_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12866-016-0752-1","article-title":"Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients","volume":"16","author":"Rampini","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijid.2016.12.014_bib0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jac\/dkn409","article-title":"Posaconazole concentrations in the central nervous system","volume":"62","author":"Ruping","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0135","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.12.014_bib0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2016.12.014_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"European Society of Clinical M, Infectious Diseases Fungal Infection Study G, European Confederation of Medical M. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2016.12.014_bib0150","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/AAC.03050-14","article-title":"Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia","volume":"58","author":"Duarte","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0155","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jac\/dkv380","article-title":"Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease","volume":"71","author":"Cornely","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2016.12.014_bib0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/myc.12309","article-title":"Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis","volume":"58","author":"Conant","year":"2015","journal-title":"Mycoses"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216316575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216316575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T21:23:11Z","timestamp":1536182591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216316575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":16,"alternative-id":["S1201971216316575"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.12.014","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}